TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 16, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Capital Expenditures (2020 - 2023)

TFA Therapeutics (RAJAF) posted Capital Expenditures of $1.2 million for Q4 2023, up 9.92% on a QoQ basis from $1.1 million in Q4 2020.

Analysis

TFA Therapeutics (RAJAF) Capital Expenditures (2020 - 2023) Analysis & Trends

TFA Therapeutics has reported Capital Expenditures for 2 years, with the latest figure at $1.2 million in Q4 2023.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Colgate Palmolive 69.71 Bn 68.67 Bn 3.30 Bn 128.00 Mn
2 Kenvue 34.22 Bn 33.11 Bn 2.30 Bn 64.00 Mn
3 Kimberly Clark 32.55 Bn 31.72 Bn 1.60 Bn 352.00 Mn
4 Bath & Body Works 3.52 Bn 2.73 Bn 692.00 Mn -
5 Prestige Consumer Healthcare 2.52 Bn 2.46 Bn - -
6 Perrigo 1.88 Bn 1.49 Bn 313.90 Mn 14.30 Mn
7 Edgewell Personal Care 1.25 Bn 854.93 Mn 242.50 Mn 15.60 Mn
8 Herbalife 1.25 Bn 883.17 Mn 1.03 Bn 11.30 Mn
9 TFA Therapeutics 1.02 Bn 1.02 Bn - -
10 Honest Company 611.15 Mn 505.26 Mn 40.36 Mn 762,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.22 Mn
Dec 31, 2020 1.11 Mn
API Access

TFA Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RAJAF&period=max&api_key=YOUR_API_KEY